🟢 ClearOne is trading 37.76% up in after-hours trading after holders approved Vivani Medical merger share issuance

ClearOne is trading at $13.50, up +37.76%, after holders representing 61.3% of voting stock approved issuing 12.5 million shares to Vivani Medical for the Cortigent merger.

• The approval removed a major transaction condition, reducing closing uncertainty; the merger is expected to create a neurotech-focused combined company.
• Reported session volume was exceptionally heavy at 64.5 million shares.
• The broader market was modestly lower, so company-specific merger news best explains the move.